Rising Demand for GLP-1 Medications Faces Access and Coverage Challenges
In recent years, the demand for GLP-1 (glucagon-like peptide-1) receptor agonists has surged, primarily due to their effectiveness in managing type 2 diabetes and aiding weight loss. However, this increased demand has coincided with significant challenges in access and insurance coverage, creating a concerning situation for patients reliant on these medications. The Demand Surge GLP-1…